Profil
Paul L.
DeAngelis is the founder of Hyalose LLC, which was founded in 2000.
He held the title of Chief Scientific Officer from 2000 to 2010.
He is also the founder of Choncept LLC, which was founded in 2002.
He currently holds the position of Chief Scientist at Choncept LLC.
Additionally, Dr. DeAngelis is currently working as a Chief Scientist at Heparinex LLC.
In terms of education, he received his undergraduate degree from Harvard University in 1984 and his doctorate degree from the University of California, Irvine in 1990.
Aktive Positionen von Paul L. DeAngelis
| Unternehmen | Position | Beginn |
|---|---|---|
Heparinex LLC
 Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Technik-/Wissenschafts-/F&E-Leiter | - |
Choncept LLC
 Choncept LLC Pharmaceuticals: MajorHealth Technology Choncept LLC produces biotechnology products. It develops chondroitin from fermentation of recombinant bacteria to replace the current chondroitin source of beef and other animal by-products. The company was founded by Paul L. DeAngelis in 2002 and is headquartered in Oklahoma City, OK. | Gründer | 31.07.2009 |
Ehemalige bekannte Positionen von Paul L. DeAngelis
| Unternehmen | Position | Ende |
|---|---|---|
Hyalose LLC
 Hyalose LLC Pharmaceuticals: MajorHealth Technology Hyalose LLC operates as a biotechnology company. It focuses on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HC). It offers Select-HA, Select-HA HiLadder, Select-HA MegaLadder, and Select-HA LoLadder. The company was founded by Paul L. DeAngelis and Paul H. Weigel in 2000 and is headquartered in Oklahoma City, OK. | Gründer | - |
Ausbildung von Paul L. DeAngelis
| Harvard University | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Heparinex LLC
Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Health Technology |
Hyalose LLC
Hyalose LLC Pharmaceuticals: MajorHealth Technology Hyalose LLC operates as a biotechnology company. It focuses on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HC). It offers Select-HA, Select-HA HiLadder, Select-HA MegaLadder, and Select-HA LoLadder. The company was founded by Paul L. DeAngelis and Paul H. Weigel in 2000 and is headquartered in Oklahoma City, OK. | Health Technology |
Choncept LLC
Choncept LLC Pharmaceuticals: MajorHealth Technology Choncept LLC produces biotechnology products. It develops chondroitin from fermentation of recombinant bacteria to replace the current chondroitin source of beef and other animal by-products. The company was founded by Paul L. DeAngelis in 2002 and is headquartered in Oklahoma City, OK. | Health Technology |
